Literature DB >> 9580577

Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.

L E Rueter1, C De Montigny, P Blier.   

Abstract

Duloxetine is a dual serotonin (5-HT)/norepinephrine (NE) re-uptake blocker with antidepressant potential. In the present in vivo electrophysiological study, the changes in the function of the rat 5-HT and NE systems after 2- and 21-day administration of duloxetine (20 mg/kg/day) were assessed in the dorsal hippocampus and the dorsal raphe nucleus (DRN). The firing rate of DRN neurons was decreased after 2 days of duloxetine, but returned to the control level after 21-day administration. This recovery of firing rate was presumably due to the desensitization of the DRN somatodendritic 5-HT1A autoreceptors found after long-term duloxetine administration. Overall serotonergic tone was assessed by examining the ability of the 5-HT1A antagonist WAY 100635 to alter hippocampal firing. WAY 100635 increased hippocampal firing rates in 21-day treated rats to a greater extent than in 2-day treated or control rats, suggesting that long-term administration induced an increase in endogenous levels of 5-HT in postsynaptic regions. This increase in 5-HT levels was accompanied by selective changes in the 5-HT and NE systems induced by long-term duloxetine administration, i.e., the desensitization of the alpha-2 adrenergic heteroreceptor on 5-HT terminals and the continued blockade of the 5-HT transporters. In contrast, the sensitivity of the alpha-2 adrenergic and terminal 5-HT1B autoreceptors, as well as that of the postsynaptic 5-HT1A receptor after 21-day treatment was unchanged. Therefore, this study demonstrates that duloxetine increases serotonergic tone in a limbic forebrain structure and may therefore be effective in the treatment of depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580577

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.

Authors:  Gerard J Marek
Journal:  Eur Neuropsychopharmacol       Date:  2008-02-21       Impact factor: 4.600

2.  Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration.

Authors:  Gerard J Marek
Journal:  Neurosci Lett       Date:  2008-04-24       Impact factor: 3.046

3.  Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.

Authors:  N Haddjeri; P Blier; C de Montigny
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 4.  Duloxetine, an antidepressant with analgesic properties - a preliminary analysis.

Authors:  Adela Hilda Onuţu
Journal:  Rom J Anaesth Intensive Care       Date:  2015-10

5.  Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion.

Authors:  Ramez Ghanbari; Mostafa El Mansari; Pierre Blier
Journal:  Psychopharmacology (Berl)       Date:  2011-03-29       Impact factor: 4.530

6.  Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.

Authors:  L E Rueter; P Blier
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice.

Authors:  Margaret Czesak; Brice Le François; Anne M Millar; Mariam Deria; Mireille Daigle; Jane E Visvader; Hymie Anisman; Paul R Albert
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

8.  Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.

Authors:  David M Marks; Manan J Shah; Ashwin A Patkar; Prakash S Masand; Geun-Young Park; Chi-Un Pae
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 9.  Role of chemoreceptors in mediating dyspnea.

Authors:  Gordon F Buchanan; George B Richerson
Journal:  Respir Physiol Neurobiol       Date:  2008-12-11       Impact factor: 1.931

10.  Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.

Authors:  Katsumasa Muneoka; Yukihiko Shirayama; Morikuni Takigawa; Seiji Shioda
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.